Carmen Marín Delgado de Robles (Roche Basel-Kaiseraugst)

article

Endotoxin testing: the international regulatory landscape

2 April 2024 | By Carmen Marín Delgado de Robles (Roche Basel-Kaiseraugst), Dr Lindsey Silva (Genentech), Evelyn Der (Genentech)

In this extract from EPR’s Pharma Horizon’s report, Evelyn Der, Lindsey Silva and Carmen Marín Delgado de Robles from Roche Group discuss the regulatory guidelines for bacterial endotoxin testing and the move towards adoption of recombinant methods.

article

Pharma’s green mission: trends in bacterial endotoxin testing

21 October 2022 | By Carmen Marín Delgado de Robles (Roche Basel-Kaiseraugst), Dr Lindsey Silva (Genentech), Dr Viviane Grunert da Fonseca (Roche Diagnostics), Evelyn Der (Genentech), Hannah Balfour (European Pharmaceutical Review)

Having recently conducted a project to implement more sustainable, reliable and efficient bacterial endotoxin testing across the global Roche corporation, those involved in the project discuss with EPR’s Hannah Balfour the key takeaways from their implementation and validation, as well as current trends in bacterial endotoxin testing.